CV Stock Price, Chart, Stats & News

CV chart
Fundamentals
Gross margin | 52.92% |
Operating margin | 1.66% |
Pretax margin | -186.59% |
Net margin | -186.77% |
Effective tax rate | -0.09% |
ROA | -139.37% |
ROE | 105.09% |
D/E | 0.07x |
Interest coverage ratio | – |
CV valuation
P/E | – |
P/S | 27.61x |
P/B | 139.07x |
P/CF | -66.22x |
P/FCF | -13.38x |
P/OCF | -66.22x |
PEG | 0.46x |
EV multiple | -12.84x |
About
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services.
Similar securities
Based on sector and market capitalization











